LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: COVID-19 patients may become predisposed to pulmonary arterial hypertension.

Suzuki, Yuichiro J / Nikolaienko, Sofia I / Shults, Nataliia V / Gychka, Sergiy G

Medical hypotheses

2021  Volume 147, Page(s) 110483

Abstract: ... Our histological evaluations revealed that patients died of COVID-19 exhibited thickened pulmonary vascular walls ... one important hallmark of pulmonary arterial hypertension (PAH). By contrast, such pulmonary vascular ... of coronavirus disease 2019 (COVID-19) that have killed over one million people worldwide so far. To date, over ...

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the current pandemic of coronavirus disease 2019 (COVID-19) that have killed over one million people worldwide so far. To date, over forty million people have officially been identified to be infected with this virus with less than 3% death rate. Since many more people are expected to have been infected with this virus without the official diagnosis, the number of people who have recovered from the SARS-CoV-2 infection should be substantial. Given the large number of people recovered from either the mild SARS-CoV-2 infection or more severe COVID-19 conditions, it is critical to understand the long-term consequences of the infection by this virus. Our histological evaluations revealed that patients died of COVID-19 exhibited thickened pulmonary vascular walls, one important hallmark of pulmonary arterial hypertension (PAH). By contrast, such pulmonary vascular remodeling lesions were not found in patients died of SARS-CoV-1 during the 2002-2004 SARS outbreak or due to the infection by H1N1 influenza. The advancement in the treatment for the human immunodeficiency virus (HIV) infection has been remarkable that HIV-infected individuals now live for a long time, in turn revealing that these individuals become susceptible to developing PAH, a fatal condition. We herein hypothesize that SARS-CoV-2 is another virus that is capable to triggering the increased susceptibility of infected individuals to developing PAH in the future. Given the large number of people being infected with SARS-CoV-2 during this pandemic and that most people recover from severe, mild or asymptomatic conditions, it is imperative to generate scientific information on how the health of recovered individuals may be affected long-term. PAH is one lethal consequence that should be considered and needs to be monitored. This may also foster the research on developing therapeutic agents to prevent PAH, which has not so far been successful.
MeSH term(s) Animals ; COVID-19/complications ; COVID-19/physiopathology ; COVID-19/virology ; Comorbidity ; Disease Outbreaks ; Disease Susceptibility ; Endothelium, Vascular/pathology ; Humans ; Influenza A Virus, H1N1 Subtype ; Influenza, Human/complications ; Lung/virology ; Models, Theoretical ; Pulmonary Arterial Hypertension/complications ; Ukraine/epidemiology
Language English
Publishing date 2021-01-06
Publishing country United States
Document type Journal Article
ZDB-ID 193145-3
ISSN 1532-2777 ; 0306-9877
ISSN (online) 1532-2777
ISSN 0306-9877
DOI 10.1016/j.mehy.2021.110483
Shelf mark
Zs.A 1132: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top